Brief: Windtree Therapeutics Inc - On March 20, Entered License And Supply Agreement With Evofem Biosciences - SEC Filing
24/03/2025 20:43
March 24 (Reuters) - Windtree Therapeutics Inc WINT.O: WINDTREE THERAPEUTICS INC - ON MARCH 20, ENTERED LICENSE AND SUPPLY AGREEMENT WITH EVOFEM BIOSCIENCES - SEC FILING Source text: [ID:n0001437749-25-008981] Further company coverage: WINT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Windtree Therapeutics
See all newsBrief: Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan
Brief: Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee For Renewed Acute Pulmonary Development By The Licensee
Brief: Windtree Therapeutics Stockholders Approve Key Proposals For Revenue And Profit Generation At The Special Stockholder Meeting
Brief: Windtree Therapeutics Terminates Seismic-C Clinical Study At 20 Enrollments - SEC Filing
Brief: Windtree Therapeutics Inc - Announces Interim Analysis Of Istaroxime Phase 2 Study